Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Bulgaria Hungary Poland Romania
  • Long-Term Follow-Up Study for Patients with Myxoid/Round Cell Liposarcoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Synovial Sarcoma Treated with Letetresgene Autoleucel

    Recruiting

    1 1 1
    Investigated Drugs:
    Italy The Netherlands Spain
  • Study on the Safety and Effectiveness of Zipalertinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with Specific EGFR Mutations

    Recruiting

    2 1 1
    Investigated Diseases:
    France Germany Italy Spain
  • Study on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Belgium
  • Study for Patients with Various Tumor Types Continuing Osimertinib Treatment After Previous Oncology Study Completion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Poland
  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Spain
  • Study on the Safety of Tremelimumab Injections for Early-Stage Non-Small Cell Lung Cancer Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France Greece Italy Portugal Romania Spain
  • Study on Imaging Non-Small Cell Lung Cancer Using 68GaNOTA-Anti-MMR VHH2 in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    Belgium
  • Study on Durvalumab and Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands